Cargando…
Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
BACKGROUND: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846287/ https://www.ncbi.nlm.nih.gov/pubmed/36686276 http://dx.doi.org/10.2147/JIR.S393495 |
_version_ | 1784871141196693504 |
---|---|
author | Jia, XiaoXiao Shi, Ming Wang, Qifei Hui, Jessica Shofaro, Joshua Hui Erkhembayar, Ryenchindorj Hui, Mizhou Gao, Chenzhe Gantumur, Munkh-Amgalan |
author_facet | Jia, XiaoXiao Shi, Ming Wang, Qifei Hui, Jessica Shofaro, Joshua Hui Erkhembayar, Ryenchindorj Hui, Mizhou Gao, Chenzhe Gantumur, Munkh-Amgalan |
author_sort | Jia, XiaoXiao |
collection | PubMed |
description | BACKGROUND: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the identification of its indications, and molecular mechanisms are of great significance for its clinical application. The previous studies showed that the clinical effects of injectable 35kDa B-HA result from B-HA binding to multiple receptors in different cells, tissues, and organs. This study lays the foundation for further studies on the comprehensive clinical effects of injectable B-HA. METHODS: We elaborated on the production process, bioactivity assay, efficacy analyses, and safety evaluation of an injectable novel HA fragment with an average molecular weight of 35 kDa (35 kDa B-HA), produced by recombinant human hyaluronidase PH20 digestion. RESULTS: The results showed that 35 kDa B-HA induced human erythrocyte aggregation (rouleaux formation) and accelerated erythrocyte sedimentation rates through the CD44 receptor. B-HA application and injection treatment significantly promoted the removal of mononuclear cells from the site of inflammation and into the lymphatic circulation. At a low concentration, 35 kDa B-HA inhibited production of reactive oxygen species and tumor necrosis factor by neutrophils; at a higher concentration, 35 kDa B-HA promoted the migration of monocytes. Furthermore, 35 kDa B-HA significantly inhibited the migration of neutrophils with or without lipopolysaccharide treatment, suggesting that in local tissues, higher concentrations of 35 kDa B-HA have antiinflammatory effects. After (99m)Tc radiolabeled 35 kDa B-HA was intravenously injected into mice, it quickly entered into the spleen, liver, lungs, kidneys and other organs through the blood circulation. CONCLUSION: This study demonstrated that the HA fragment B-HA has good tissue permeability and antiinflammatory effects, laying a theoretical foundation for further clinical studies. |
format | Online Article Text |
id | pubmed-9846287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-98462872023-01-19 Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) Jia, XiaoXiao Shi, Ming Wang, Qifei Hui, Jessica Shofaro, Joshua Hui Erkhembayar, Ryenchindorj Hui, Mizhou Gao, Chenzhe Gantumur, Munkh-Amgalan J Inflamm Res Original Research BACKGROUND: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the identification of its indications, and molecular mechanisms are of great significance for its clinical application. The previous studies showed that the clinical effects of injectable 35kDa B-HA result from B-HA binding to multiple receptors in different cells, tissues, and organs. This study lays the foundation for further studies on the comprehensive clinical effects of injectable B-HA. METHODS: We elaborated on the production process, bioactivity assay, efficacy analyses, and safety evaluation of an injectable novel HA fragment with an average molecular weight of 35 kDa (35 kDa B-HA), produced by recombinant human hyaluronidase PH20 digestion. RESULTS: The results showed that 35 kDa B-HA induced human erythrocyte aggregation (rouleaux formation) and accelerated erythrocyte sedimentation rates through the CD44 receptor. B-HA application and injection treatment significantly promoted the removal of mononuclear cells from the site of inflammation and into the lymphatic circulation. At a low concentration, 35 kDa B-HA inhibited production of reactive oxygen species and tumor necrosis factor by neutrophils; at a higher concentration, 35 kDa B-HA promoted the migration of monocytes. Furthermore, 35 kDa B-HA significantly inhibited the migration of neutrophils with or without lipopolysaccharide treatment, suggesting that in local tissues, higher concentrations of 35 kDa B-HA have antiinflammatory effects. After (99m)Tc radiolabeled 35 kDa B-HA was intravenously injected into mice, it quickly entered into the spleen, liver, lungs, kidneys and other organs through the blood circulation. CONCLUSION: This study demonstrated that the HA fragment B-HA has good tissue permeability and antiinflammatory effects, laying a theoretical foundation for further clinical studies. Dove 2023-01-13 /pmc/articles/PMC9846287/ /pubmed/36686276 http://dx.doi.org/10.2147/JIR.S393495 Text en © 2023 Jia et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Jia, XiaoXiao Shi, Ming Wang, Qifei Hui, Jessica Shofaro, Joshua Hui Erkhembayar, Ryenchindorj Hui, Mizhou Gao, Chenzhe Gantumur, Munkh-Amgalan Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) |
title | Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) |
title_full | Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) |
title_fullStr | Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) |
title_full_unstemmed | Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) |
title_short | Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) |
title_sort | anti-inflammatory effects of the 35kda hyaluronic acid fragment (b-ha/ha35) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846287/ https://www.ncbi.nlm.nih.gov/pubmed/36686276 http://dx.doi.org/10.2147/JIR.S393495 |
work_keys_str_mv | AT jiaxiaoxiao antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT shiming antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT wangqifei antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT huijessica antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT shofarojoshuahui antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT erkhembayarryenchindorj antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT huimizhou antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT gaochenzhe antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 AT gantumurmunkhamgalan antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35 |